Alerts will be sent to your verified email
Verify Email
FISCHER
|
Fischer Medical
|
NOCIL
|
Rossari Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.29 % | 8.47 % | 13.49 % |
|
5yr average Equity Multiplier
|
0.49 | 1.22 | 1.73 |
|
5yr Average Asset Turnover Ratio
|
0.4 | 0.74 | 1.03 |
|
5yr Avg Net Profit Margin
|
-4.14 % | 9.32 % | 7.62 % |
|
Price to Book
|
6.55 | 1.27 | 2.1 |
|
P/E
|
59.8 | 37.88 | 19.08 |
|
5yr Avg Cash Conversion Cycle
|
140.14 Days | 115.35 Days | 70.18 Days |
|
Inventory Days
|
33.45 Days | 63.49 Days | 43.64 Days |
|
Days Receivable
|
163.11 Days | 85.23 Days | 78.74 Days |
|
Days Payable
|
23.17 Days | 51.92 Days | 64.07 Days |
|
5yr Average Interest Coverage Ratio
|
12.88 | 135.89 | 15.5 |
|
5yr Avg ROCE
|
3.71 % | 10.21 % | 16.45 % |
|
5yr Avg Operating Profit Margin
|
6.78 % | 14.27 % | 13.54 % |
|
5 yr average Debt to Equity
|
-0.66 | 0.0 | 0.07 |
|
5yr CAGR Net Profit
|
n/a | 3.07 % | 11.2 % |
|
5yr Average Return on Assets
|
-4.27 % | 6.95 % | 7.91 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
61.8 % | 33.76 % | 68.16 % |
|
Share Pledged by Promoters
|
0.0 | 18.66 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
61.8 % | -0.08 % | -0.28 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 2.27 % | 0.83 % |
|
Fischer Medical
|
NOCIL
|
Rossari Biotech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|